The global homecare diagnostics & therapeutics market size is calculated at USD 249.93 billion in 2024, grew to USD 269.92 billion in 2025, and is predicted to hit around USD 539.57 billion by 2034, expanding at a CAGR of 8% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Homecare Diagnostics and Therapeutics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Homecare Diagnostics and Therapeutics Market, by Product Type, 2024-2034
8.1.1. Diagnostics
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Therapeutics
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Mobility Care Products
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Homecare Diagnostics and Therapeutics Market, by Service, 2024-2034
9.1.1. Rehabilitation Therapy Services
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Skilled Nursing Services
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Respiratory Therapy Services
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Pregnancy Care Services
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Infusion Therapy Services
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2021-2034)
10.1. Homecare Diagnostics and Therapeutics Market, by Indication, 2024-2034
10.1.1. Cardiovascular Disorders
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Cancer
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Diabetes
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Respiratory Diseases
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Wound Care
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Forecast, by Service (2021-2034)
11.1.3. Market Revenue and Forecast, by Indication (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Service (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Indication (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Service (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Indication (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Forecast, by Service (2021-2034)
11.2.3. Market Revenue and Forecast, by Indication (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Service (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Indication (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Service (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Indication (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Service (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Indication (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Service (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Indication (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Forecast, by Service (2021-2034)
11.3.3. Market Revenue and Forecast, by Indication (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Service (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Indication (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Service (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Indication (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Service (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Indication (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Service (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Indication (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Forecast, by Service (2021-2034)
11.4.3. Market Revenue and Forecast, by Indication (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Service (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Indication (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Service (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Indication (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Service (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Indication (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Service (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Indication (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Forecast, by Service (2021-2034)
11.5.3. Market Revenue and Forecast, by Indication (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Service (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Indication (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Service (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Indication (2021-2034)
12.1. Fresenius SE & Co. KGaA
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GE Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Linde plc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. F. Hoffmann-La Roche Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. A&D Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. BAYADA Home Health Care
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Invacare Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Abbott
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Amedisys
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. ResMed
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample